Edition:
United States

Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

193.08USD
18 Jul 2019
Change (% chg)

$3.32 (+1.75%)
Prev Close
$189.76
Open
$190.17
Day's High
$194.15
Day's Low
$190.00
Volume
355,858
Avg. Vol
361,504
52-wk High
$197.30
52-wk Low
$134.53

About

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan... (more)

Overall

Beta: 0.87
Market Cap(Mil.): $40,257.49
Shares Outstanding(Mil.): 208.50
Dividend: --
Yield (%): --

Financials

  EW.N Industry Sector
P/E (TTM): 51.53 102.68 34.10
EPS (TTM): 3.75 -- --
ROI: 17.11 6.08 12.64
ROE: 23.86 8.53 17.18

FDA ties three deaths to Edwards Lifesciences' recalled heart devices

The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences Corp's recall of some of its heart devices.

Jul 01 2019

UPDATE 2-FDA ties three deaths to Edwards Lifesciences' recalled heart devices

July 1 The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences Corp's recall of some of its heart devices.

Jul 01 2019

FDA says three deaths related to Edwards Lifesciences' recalled heart devices

July 1 The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences Corp's recall of some of its heart devices.

Jul 01 2019

Edwards, Medtronic heart valve systems prove worth in low-risk patients -studies

Non-invasive heart valve replacement systems from Medtronic Plc and rival Edwards Lifesciences Corp proved as good or better than open heart surgery in younger, more active patients for whom the surgical option was deemed low risk, according to trial results that had been scheduled to be presented on Sunday.

Mar 16 2019

CORRECTED-Edwards, Medtronic heart valve systems prove worth in low-risk patients -studies

March 16 Non-invasive heart valve replacement systems from Medtronic Plc and rival Edwards Lifesciences Corp proved as good or better than open heart surgery in younger, more active patients for whom the surgical option was deemed low risk, according to trial results that had been scheduled to be presented on Sunday.

Mar 16 2019

Edwards Lifesciences beats on revenue but forecast lags estimates

U.S. medical device maker Edwards Lifesciences narrowly topped Wall Street estimates for quarterly revenue on Thursday as it sold more heart monitors, but its outlook for March quarter earnings fell below analysts' forecasts.

Jan 31 2019

Edwards Lifesciences beats on revenue but forecast lags estimates

Jan 31 U.S. medical device maker Edwards Lifesciences narrowly topped Wall Street estimates for quarterly revenue on Thursday as it sold more heart monitors, but its outlook for March quarter earnings fell below analysts' forecasts.

Jan 31 2019

Chinese man gets prison for stealing trade secrets from ev3, Edwards

A Chinese man who worked at medical device manufacturers ev3 Inc and Edwards Lifesciences Corp has been sentenced to 27 months in prison for stealing trade secrets from them in order to make products at a company that had Chinese government funding.

Jan 29 2019

Earnings vs. Estimates